Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines

The Journal of Infectious Diseases
R DaganP Yagupsky

Abstract

Nasopharyngeal carriage of Streptococcus pneumoniae was studied in 162 healthy infants at ages 2, 4, 6, 7, 12, and 13 months and in an additional 352 healthy children at ages 12, 15, 18, 21, and 24 months. Carriage was 26%, 39%, and 62% at 2, 12, and 24 months, respectively, and the respective resistance to > or = 1 antibiotic was 11%, 19%, and 27%. The presence of an older sibling or antibiotic treatment during the month preceding the culture was associated with carriage of resistant pneumococci in infants, whereas attendance at large day care centers was associated with carriage during the second year of life. Antibiotic resistance was detected in all 7 serotypes included in the candidate pediatric conjugate vaccines and was significantly more prevalent among vaccine-type pneumococci than among non-vaccine-type pneumococci. The use of conjugate vaccines may reduce the spread of resistant pneumococci.

Citations

Mar 25, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R Dagan
Mar 7, 2002·International Journal of Pediatric Otorhinolaryngology·Michael D PooleChristopher J Harrison
Jun 22, 1999·International Journal of Pediatric Otorhinolaryngology·F GordtsL Kaufman
Nov 30, 1999·International Journal of Pediatric Otorhinolaryngology·A LeibermanD M Fliss
Apr 23, 2003·Vaccine·Katherine L O'Brien, Ron Dagan
Aug 5, 2000·International Journal of Antimicrobial Agents·E Leibovitz, R Dagan
Nov 24, 1999·International Journal of Antimicrobial Agents·L LatiniR Ronchetti
Mar 6, 1999·Current Opinion in Microbiology·J B McCormick
Jul 18, 2002·Scandinavian Journal of Immunology·T Wuorimaa, H Käyhty
Mar 9, 2000·The New England Journal of Medicine·J P NuortiR F Breiman
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N Givon-LaviN Porat
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F GhaffarG H McCracken
Jul 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A BorerP Yagupsky
Jan 26, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph P Lynch III, Fernando J Martinez
Aug 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel R Feikin, Keith P Klugman
Nov 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George A SyrogiannopoulosNicholas G Beratis
Nov 5, 1997·The Pediatric Infectious Disease Journal·Z el-AstalP Yagupsky
Nov 5, 1998·The Pediatric Infectious Disease Journal·M R Jacobs
Jul 3, 1999·The Pediatric Infectious Disease Journal·J Eskola, M Anttila
Aug 10, 1999·The Pediatric Infectious Disease Journal·F GhaffarG H McCracken
Apr 17, 2001·The Pediatric Infectious Disease Journal·C L ColesJ M Tielsch
Dec 6, 2001·The Pediatric Infectious Disease Journal·T LeinoA K Takala
Jun 12, 2003·The Pediatric Infectious Disease Journal·Noga Givon-LaviRon Dagan
Feb 11, 2005·The Pediatric Infectious Disease Journal·Helena KäyhtyLennart Nilsson
Sep 9, 2005·The Pediatric Infectious Disease Journal·Ritva K SyrjänenP Helena Mäkelä
Nov 26, 2009·The Pediatric Infectious Disease Journal·Caritas M FrancoMaria-Cristina de Cunto Brandileone
Sep 5, 2007·Archives of Disease in Childhood·Anita RocheYvonne Young
Sep 29, 2004·Journal of Clinical Pathology·Q Zhang, A Finn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.